Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01057576 · ClinicalTrials.gov registry record · Phase 1
Safety and Efficacy Study of Tarragon on Insulin Action in Humans
A Phase 1 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT01057576 is a Phase 1 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 28 participants.
The verdict
NCT01057576, a Phase 1 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
Specific compounds in plants have been proposed to enhance human metabolism. The hypothesis of the study was to evaluated the effect of an extract of Russian tarragon and to determine is compounds in the plant can be measured in the serum of human subjects and whether the compound may improve human metabolism as suggested in animal studies.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT An alcoholic extract of Artemisia dracunculus L.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01057576
The ClinicalTrials.gov registry entry for NCT01057576 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01057576 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01057576 about?
NCT01057576 is a clinical study titled "Safety and Efficacy Study of Tarragon on Insulin Action in Humans". Specific compounds in plants have been proposed to enhance human metabolism. The hypothesis of the study was to evaluated the effect of an extract of Russian tarragon and to determine is compounds in the plant can be measured in the serum of human subjects and whether the compound may improve human ...
What is the current status of trial NCT01057576?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2006-03. Estimated completion is 2008-10.
What interventions are being tested in trial NCT01057576?
The interventions under investigation include: Placebo (OTHER), An alcoholic extract of Artemisia dracunculus L. (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01057576?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.